In order to investigate the effect of long-term glycemic control on the urinary albumin excretion rate (AER:μg/min) in non-insulin dependent diabetes mellitus (NIDDM), AER and HbA
1 in 43 patients with NIDDM were traced for 12 to 18 months.
Microalbuminuria was defined as AER of 20μg/min or more because the mean (±SD) AER value of 33 healthy controls was 9.5±5.2 μg/min. Microalbuminuria and normoalbuminuria were found in 17 (group A) and 26 (group B) diabetics, respectively. According to the mean HbA
1, value in the last 6 months (last HbA
1) of this study, group A and B were divided into 6 subgroups as follows. HbA
1 <8.0%; A-S, B-S, 8.0-9.0%; A-G, B-S, ≥9.0%; A-P, B-P. In addition, renal biopsy was performed in 9 cases of group A to assess the relationship between the consequences of AER and diabetic renal lesions. The following results were obtained.
1) AER was normalized in 2 of 5 cases in A-S and 2 of 4 in group A-G, and was improved in 1 of 4 in group A-G, and was exacerbated in 3 of 8 in group A-P. Compared with the mean HbA
1 value (9.4±1.0%) of the preceding 6 months of this survey, the last HbA
1 (7.7±0.8%) was significantly decreased in 4 patients with normalized AER (p<0.05).
2) Progression to intermittent or persistent microalbuminuria was observed in 1 of 8 cases in group B-S, 1 of 7 in group B-G and 4 of 11 in group B-P.
3) AER was normalized even in 2 patients with a diffuse lesion of grade III and a nodular lesion of grade I nephropathy when HbA
1 was improved from 8.4 and 10.7% to 7.1 and 8.7%, respectively.
From these results it was concluded that (1) microalbuminuria could be normalized when HbA
1, above 9.0% was improved to below 9.0%, or when HbA
1 of 8.0-9.0% was improved to below 8.0%, but (2) microalbuminuria could not be ameliorated when HbA
1 remained above 9.0% in spite of the improvement in glycemic control.
View full abstract